A/Prof Ingrid Hopper is a clinician-researcher in cardiovascular medicine and clinical pharmacology whose work focuses on optimising therapeutic care for patients with heart failure and improving cardiovascular health in ageing populations. Her research integrates clinical trials, epidemiology and real-world registry data to evaluate the effectiveness, safety and implementation of pharmacological therapies in complex, multimorbid patients. She leads and contributes to major prevention and healthy-ageing studies, including investigations of statin therapy and cardiac ageing (STAREE-HEART), while also advancing evidence-based models of care that translate guideline recommendations into routine practice. A central theme of her work is medication optimisation - addressing polypharmacy, deprescribing and treatment sequencing to improve patient outcomes and disability-free survival. Her research spans therapeutics, health-system improvement and population cardiovascular prevention.